NOTTINGHAM, UK. 3rd April, 2025 – 4D Biomaterials Ltd, the materials manufacturing subsidiary of 4D Medicine Ltd, a UK university spin-out company developing next-generation bioresorbable medical devices, today announced it has achieved ISO 13485:2016 certification from The British Standards Institution (BSI). 

This globally recognised quality standard for medical device manufacturing marks a critical milestone in the company’s path to market, demonstrating high quality, low risk and customer-focused manufacturing capability. 

The certification confirms that 4D Biomaterials Ltd operates under a quality management system that meets stringent international regulatory requirements — a core prerequisite for the raw materials used in medical devices seeking regulatory approvals, clinical deployment, and global distribution. As such, certification significantly de-risks the company’s commercial strategy. 

Phil Smith, CEO of parent company, 4D Medicine Ltd commented:

“This achievement is a pivotal moment for our materials manufacturing business. ISO 13485 certification validates its operational systems and sends a clear signal to partners and investors: we are ready to scale. It also reflects the maturity of our technology platform, the discipline of our team, and our commitment to executing a high-quality commercialisation strategy.”

This milestone positions 4D to accelerate the development of commercial partnerships, regulatory approvals, and revenue-generating opportunities as it advances its differentiated product pipeline toward global markets.

ENDS

MERSEYSIDE, UK. March 26th, 2025 – Reflect Clinic is inviting mothers to rediscover their sense of self this Mother’s Day with their bespoke Mummy Makeover procedure –  a personalised surgery designed to help women feel like the best version of themselves again.

The Mummy Makeover addresses the most common post-pregnancy concerns, combining treatments such as breast uplifts, breast reductions, tummy tucks, and liposuction. 

These targeted procedures help to restore pre-pregnancy physiques, tackling issues such as sagging skin, stubborn fat, and abdominal muscle separation that exercise and healthy habits often cannot resolve.

Led by renowned cosmetic surgeon Mr. Gerard Lambe, Reflect Clinic’s patient-focused approach is at the heart of its offering. One recent patient shared her uplifting experience, highlighting the professionalism and warmth of the Reflect Clinic team.

“My two consultations elsewhere had personal connections,” she said.

“So I wasn’t sure I needed a third. Well, I couldn’t have been more wrong. After a few initial emails with Jayne, I was immediately at ease when we met, welcomed extremely warmly and engulfed by her affable nature.

“Research already showed me that Mr Lambe was an exceptional cosmetic surgeon, but upon meeting him, he was warm and funny and put me at ease. He gave me time (most important to me) and advice, no pressure or sales, answered my (usually) daft questions without judgment, and encouraged me to ask more. 

“Every single person that looked after me on the big day was lovely. I couldn’t be happier with the experience and the result. I felt so comfortable with the whole Spire Manchester experience that before I left the building, I knew I would be choosing the Reflect Clinic.”

Performed by Mr. Gerard Lambe, the Mummy Makeover provides more than just aesthetic results. It offers women an opportunity to reclaim their confidence and physical comfort after the life-changing experiences of childbirth and motherhood. 

With a dedicated team and supportive environment, Reflect Clinic ensures that every patient feels empowered throughout their transformation.

For mothers considering this step, Reflect Clinic offers useful resources such as the guide Is a Mummy Makeover Right for You?, which details the benefits and considerations of the procedure. 

The Clinic prioritises education, transparency, and outstanding care to help mothers make informed decisions.

To explore more about the Mummy Makeover and how Reflect Clinic can support you, or to book a consultation, visit the Reflect Clinic website. For direct enquiries, contact their friendly team today.

This Mother’s Day, Reflect Clinic celebrates the strength and beauty of every mother, encouraging women to take time for themselves, rediscover their confidence, and invest in their self-love.

For more information about Mummy Makeover or to book a consultation, contact Reflect Clinic at hello@reflectclinic.co.uk.

ENDS

London, UK. March 19th, 2025 – Trilateral Research is working to create an innovative AI-powered screening tool for early melanoma detection.

Partnered with healthcare providers, AI developers, and research institutions as part of the iToBoS Project (Intelligent Total Body Scanner for Early Detection of Melanoma), the new system will integrate AI with advanced imaging to provide a more comprehensive view of skin health. 

A key challenge in AI-driven skin cancer detection is bias, as many existing tools rely on datasets that lack diversity. This limitation increases the risk of inaccurate or delayed diagnoses, particularly for underrepresented groups. 

Trilateral is focused on minimising bias in the iToBoS tool, making it more equitable, transparent, and effective across diverse skin types. The team is also working with partners to reduce bias in AI-driven skin cancer detection, to ensure consistent and equitable outcomes for all patients. 

Trilateral evaluated the AI-driven system within the iToBoS project to ensure it operates fairly, transparently, and inclusively, with a diverse and representative dataset. 

A crucial part of this effort is the Risk Assessment Model, developed by the National Technical University of Athens (NTUA), which measures the reliability of the AI’s diagnostic decisions and identifies areas for improvement. Trilateral’s experts provided targeted recommendations to improve inclusivity, strengthen decision-making, and ensure the tool delivers accurate and fair diagnoses for all patients. 

Trilateral and its partners are refining how the AI processes and learns from patient data, expanding its ability to accurately detect melanoma across all skin types. By incorporating best practices for fairness and transparency, they are ensuring the system is both reliable and adaptable to real-world clinical settings. The iToBoS project aligns with Trilateral’s broader mission to ensure AI technology is used responsibly and meets ethical and regulatory standards. 

The iToBoS project is shaping the future of medical AI. By setting new standards for fairness and responsible deployment, it is paving the way for more inclusive and effective AI-driven healthcare solutions. Trilateral Research remains dedicated to advancing AI solutions that prioritise patient safety, accuracy, and fairness, ensuring that emerging technologies benefit all communities equitably. 

To find out more about Trilateral Research, its products, services or research innovations, visit: https://trilateralresearch.com/contact-us 

-ENDS-

IPSWICH, UK. March 17th, 2025 – UK men’s mental health charity MANUP? has announced the extension of its support for groundbreaking independent research into male suicide – the leading cause of death for men under 50 in the UK.

Since 2024, MANUP? has been funding research by Dr Susie Bennett, male suicide researcher at Glasgow University’s Suicide Research Lab. Dr Susie’s work has been has focused on trying to understand why men are more at risk of suicide and what can be done to help more men access a dignified and meaningful life.

Male suicide remains a public health crisis, with suicide being the leading cause of death for men under 50 in the UK. Despite widespread awareness campaigns, many men who seek help still do not receive the support they need. Research funded by MANUP? is tackling this issue head-on by uncovering the real reasons behind the crisis and what must change to reduce these devastating numbers.

“Evidence from our research shows men who are suicidal are going for help but not always getting the support they need,” said Dr Susie Bennett. “This shows the current ‘just talk’ approach is not enough. We need to rethink how we support men and create interventions that actually work.”

Thanks to the support of its fundraisers, MANUP? has been able to keep this vital research going while also reaching thousands of people across the UK. Over the past year, the charity has hosted free events nationwide, bringing together key decision-makers, including town mayors, NHS directors, government officials, headteachers and charity leaders, to drive meaningful discussions and action.

Dan Somers, Founder and CEO of MANUP?, said: “We are proud to be able to support Dr Susie’s Bennett’s research for another year. I believe it says a lot, not only about us as a charity but also larger charities and government bodies, that there is a need to continue with the funding for this critical research from a small charity like ours.

“At MANUP?, we don’t just raise awareness. We take action. Funding this research is about ensuring that when men do reach out for help, they actually get it. The numbers show they aren’t, and that needs to change.

“Unlike other mental health charities, which primarily rely on their own internal data, we’re funding independent UK-based research to provide a clearer picture of what is happening on the ground. By continuing to support this work, we are ensuring that real-world solutions are developed based on the lived experiences of men in the UK, rather than assumptions or imported statistics.”

For more information on Dr Susie Bennett’s research, visit: www.manup.how/research

ENDS

NOTTINGHAM, UK. March 11th, 2025 – 4D Medicine Ltd, an emerging innovator in the biomaterials and medical device sector, is proud to announce the launch of its newly redesigned corporate website, www.4dmedicine.co.uk.

The site is designed to offer a comprehensive resource for investors, strategic partners, and healthcare professionals, highlighting the company’s groundbreaking 4Degra® bioabsorbable polymer technology and its potential to transform the medical device industry.

The new website offers information on the unique properties of 4Degra®, a next-generation bioabsorbable polymer developed to improve patient outcomes in medical device applications. 4Degra®’s unparalleled versatility and biocompatibility make it an ideal material for a wide range of devices, including those used in musculoskeletal repair, soft tissue regeneration and drug-delivery.

“4Degra® represents the next evolution in bioabsorbable materials, and this website serves as an essential tool to communicate the exciting opportunities that lie ahead for investors and collaborators,” said Phil Smith, CEO of 4D Medicine. 

“We’ve designed the site to not only inform but to also demonstrate the potential impact our technology can have in improving surgical outcomes and improving lives.”

Key features of the new website include:

The launch of this website underscores 4D Medicine’s commitment to transparency, collaboration, and ongoing innovation. The company is poised to lead the way in delivering solutions that enhance patient care and create lasting value for its partners and stakeholders.

ENDS

AYLESBURY, UK. February 26th, 2025 – Amparo, a leader in direct-fit prosthetic sockets, has acquired Adapttech, a pioneer in smart prosthetic technology. This acquisition creates a combined entity poised to reshape the orthotics and prosthetics (O&P) industry.

The merger of both companies combines Amparo’s extensive experience in direct-fit socket technology and Adapttech’s cutting-edge advancements in data-driven prosthetic care. This synergy will lead to:

“This alliance unlocks incredible potential,” said Wesley Teerlink, CEO of Amparo. “We’re merging highly complementary technologies and building a powerhouse of innovation. The most exciting part is uniting our talented teams – I see a phenomenal future for the combined company.”

Frederico Carpinteiro, CEO of Adapttech, echoed this sentiment. He said: “We’re thrilled to join Amparo and its exceptional team. This deal presents tremendous growth opportunities and allows us to reach more people faster, significantly amplifying the impact of our technologies. I eagerly anticipate this new chapter and all it holds.”

Amparo will continue offering its full range of direct-fit sockets. Additionally, the expanded product portfolio will now include Adapttech’s innovative Motio Functional Reports, empowering patients with advanced data-driven prosthetic care.

ENDS

STAFFORDSHIRE, UK. February 24th, 2025 – Following the success of its inaugural session, Coauthor by Hindsight, a developer-friendly compliance software solution for medical device development, is pleased to announce the next webinar in its ongoing Medical Device Cybersecurity webinar series.

Titled “Software Supply Chain: Know Your SBOMs from Your SOUP”, this session will provide essential insights into managing software supply chain risks and understanding the role of Software Bill of Materials (SBOMs) in medical device security, and how this differs from Software of Unknown Provenance (SOUP). The webinar will take place on Thursday, 20th March 2025, at 12:30 PM GMT.

Medical device manufacturers, regulatory affairs professionals, and software developers will benefit from expert-led discussions on:

Software vulnerabilities in the medical device supply chain present a growing cybersecurity challenge. Regulatory bodies are increasingly mandating the use of SBOMs to enhance transparency, mitigate risks, and improve post-market monitoring of medical device security.

This 30-minute webinar is an unmissable opportunity for professionals looking to enhance their cybersecurity strategies, reduce compliance burdens, and gain practical knowledge of supply chain security management. 

The session will be led by Alan Parkinson, CEO of Hindsight Software, and co-presented by Dr. Heather Carre-Skinner, an expert in Regulatory & Quality Compliance for Medical Devices and SaMD.

Register Today!

The webinar is free to attend, but spaces are limited. Secure your place now at: https://www.coauthor.app/webinars 

LEATHERHEAD, UK. February 21st, 2025 – BridgeHead Software, a leading provider of clinical data management solutions, is delighted to announce its membership as a Founding Partner of the newly formed UK Electronic Patient Record (EPR) Network. 
 
The UK Electronic Patient Record (EPR) Network is a newly established industry-funded initiative designed to accelerate NHS digital transformation. Founded by Hadleigh Stollar, CEO of the Healthcare Innovation Consortium (HIC), the network brings together key stakeholders – including healthcare professionals, policymakers, EPR providers, and supporting vendors – to collaborate on best practices, share expertise, and drive innovation. By fostering a connected ecosystem, the EPR Network aims to enhance interoperability, improve efficiencies, and advance the digitisation of healthcare across the NHS.

Supporting NHS Digital Transformation

As a Founding Partner of the EPR Network, BridgeHead Software continues to demonstrate its dedication to supporting the NHS with interoperable data management solutions that enhance clinical efficiency, increase productivity and, ultimately, improve patient outcomes. 

BridgeHead, a global company headquartered in the UK, is 100% dedicated to healthcare, with over 30 years of experience delivering data management solutions to customers around the world. Its Clinical Data Repository (CDR), HealthStore®, complements systems such as EPR, PACS, LIMS, and RIS; enabling healthcare organisations to consolidate data from live and legacy systems into a single, standards-based platform. HealthStore integrates with EPR solutions to facilitate secure, fast, and interoperable access to patient information residing outside of the EPR, supporting both frontline services as well as secondary uses, such as clinical research.

Driving Collaboration And Innovation Across the EPR Ecosystem

John McCann, Vice President of Global Marketing at BridgeHead Software, said: “BridgeHead is excited to join the EPR Network and collaborate with members to advance the NHS’ digital transformation agenda. This partnership provides an invaluable opportunity to share our expertise in Clinical Data Management while learning from NHS peers and other vendors across the sector. Together, we aim to drive better health for populations, better care for patients, and increased operational efficiencies through technology.”

Hadleigh Stollar, Founder and CEO at HIC, added: “We are thrilled to welcome BridgeHead Software as a Founding Partner of the EPR Network. Their expertise in Clinical Data Management and dedication to supporting the NHS’ digital goals make them a valuable addition to the network. We look forward to working with BridgeHead and our other members to help address the challenges and opportunities for healthcare digitisation throughout the NHS.”

For more information about BridgeHead Software and its solutions, visit: www.bridgeheadsoftware.com

ENDS

Furthering its commitment to Enterprise Imaging in healthcare 

WOBURN, MA. 19th February, 2025 – BridgeHead Software, a leading provider of healthcare data management solutions, is thrilled to announce its membership with the Society for Imaging Informatics in Medicine (SIIM). SIIM is an international community of Imaging Informaticists united by their curiosity and commitment to advancing medical imaging through innovation, research, and education. This membership marks an exciting milestone in BridgeHead’s journey to support the global healthcare community with cutting-edge solutions that enhance imaging workflows, foster interoperability, and improve patient outcomes.

 

As a community, SIIM brings together scientists, developers, vendors, imaging IT experts, and clinicians from around the world to tackle the challenges associated with medical imaging. By joining SIIM, BridgeHead Software aims to collaborate with industry leaders, share expertise, and contribute to the development of next-generation imaging informatics solutions.

 

For over 30 years, BridgeHead Software has dedicated itself to pioneering solutions that address real-world data management issues for healthcare providers and clinical networks. Its award-winning, interoperable Clinical Data Repository (CDR), HealthStore®, augments systems such as EHR, PACS, LIMS, RIS, and more; by breaking down departmental and organizational data silos, and bringing together live and legacy data from across the healthcare ecosystem to provide a rich, longitudinal patient record.

 

The strength of HealthStore comes from its support for industry standards, such as FHIR; which enables it to aggregate a wide array of patient data spanning medical images, clinical reports, lab results, scanned documents and other essential clinical information; and making it available to clinicians to better support care decisions and improve patient outcomes. This data can be accessed via the EHR or other primary systems to streamline clinical workflows and increase productivity – supporting frontline clinical services as well as secondary uses, such as research and innovation in medical imaging.

 

Cheryl Kreider Carey, MBA, CAE, Chief Executive Officer at SIIM, welcomed the announcement: “We are delighted to have BridgeHead Software join the SIIM community. Their expertise in healthcare data management aligns perfectly with our mission to advance medical imaging through innovation and collaboration. We look forward to the insights and contributions BridgeHead will bring to our community as we work together to shape the future of imaging informatics.”

 

Jim Beagle, President and CEO at BridgeHead Software, commented: “Joining SIIM provides BridgeHead with an incredible platform to collaborate with a global network of innovators in imaging informatics. SIIM’s dedication to research, education, and advancing technology resonates with our mission to empower healthcare providers with solutions that enhance clinical efficiency, reduce operational risk, and improve patient care. We are excited to actively participate and contribute to the SIIM community.”

 

The SIIM membership underscores BridgeHead Software’s dedication to pushing the boundaries of medical imaging technology and supporting healthcare providers worldwide in their digital transformation journeys.

 

For more information about BridgeHead Software and its solutions, visit www.bridgeheadsoftware.com.